Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide

Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide

Seaweed polysaccharides in the diet may influence both inflammation and the gut microbiome. Here we describe two clinical studies with an <i>Ulva</i> sp. 84-derived sulfated polysaccharide—“xylorhamnoglucuronan” (SXRG84)—on metabolic markers, inflammation, and gut flora composition. The...

Full description

Bibliographic Details
Main Authors: Lauren A. Roach, Barbara J. Meyer, J. Helen Fitton, Pia Winberg
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Marine Drugs
Subjects:
seaweed
metabolic syndrome
prediabetes
sulfated polysaccharide
anti-inflammation
cholesterol
Online Access:https://www.mdpi.com/1660-3397/20/8/500

Internet

https://www.mdpi.com/1660-3397/20/8/500

Similar Items